financetom
Business
financetom
/
Business
/
Lazard Q3 Adjusted Earnings Rise, Revenue Falls
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lazard Q3 Adjusted Earnings Rise, Revenue Falls
Oct 23, 2025 4:21 AM

06:57 AM EDT, 10/23/2025 (MT Newswires) -- Lazard ( LAZ ) reported Q3 adjusted earnings Thursday of $0.56 per diluted share, up from $0.38 a year earlier.

Analysts polled by FactSet expected $0.44.

Total revenue for the quarter ended Sept. 30 was $770.8 million, compared with $807.4 million a year earlier.

Analysts surveyed by FactSet expected $717.6 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bitfarms reaches agreement with Riot, Freedman appointed to board
Bitfarms reaches agreement with Riot, Freedman appointed to board
Oct 3, 2024
(Reuters) - Bitcoin miner Bitfarms ( BITF ) said on Monday it had entered into a settlement agreement with rival and top shareholder Riot Platforms ( RIOT ), under which Amy Freedman was appointed to its board. Freedman, a former investment banker who has helped companies with corporate governance matters, will replace Andrés Finkielsztain on the Bitfarms ( BITF )...
Carlyle-backed StandardAero targets $7.5 billion valuation in US IPO
Carlyle-backed StandardAero targets $7.5 billion valuation in US IPO
Oct 3, 2024
(Reuters) - Aviation service provider StandardAero, backed by buyout firm Carlyle Group, said on Monday it is seeking a valuation of up to $7.5 billion in its initial public offering in the United States. The company is targeting proceeds of up to $1.07 billion, selling 46.5 million shares priced between $20 and $23 each. The IPO comes as the aviation...
Viking Therapeutics Insider Sold Shares Worth $715,850, According to a Recent SEC Filing
Viking Therapeutics Insider Sold Shares Worth $715,850, According to a Recent SEC Filing
Oct 3, 2024
07:29 AM EDT, 09/23/2024 (MT Newswires) -- Matthew J Singleton, Director, on September 20, 2024, sold 10,300 shares in Viking Therapeutics ( VKTX ) for $715,850. Following the Form 4 filing with the SEC, Singleton has control over a total of 9,500 shares of the company, with 9,500 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1607678/000095017024108577/xslF345X05/ownership.xml Price: 70.86, Change: +0.39, Percent Change:...
HighPeak Energy Insider Bought Shares Worth $1,554,000, According to a Recent SEC Filing
HighPeak Energy Insider Bought Shares Worth $1,554,000, According to a Recent SEC Filing
Oct 3, 2024
07:12 AM EDT, 09/23/2024 (MT Newswires) -- Jack Hightower, 10% Owner, Director, Chief Executive Officer, on September 20, 2024, executed a purchase for 100,000 shares in HighPeak Energy ( HPK ) for $1,554,000. Following the Form 4 filing with the SEC, Hightower has control over a total of 86,200,645 shares of the company, with 4,959,255 shares held directly and 81,241,390...
Copyright 2023-2026 - www.financetom.com All Rights Reserved